Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma

Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma

Aim: To evaluate optimal systemic therapy sequencing (first-line targeted therapy (1L-TT) vs. first-line immunotherapy (1L-IO)) in patients with BRAF-mutated metastatic melanoma. Methods: Nation-wide prospective data of patients with newly diagnosed BRAF-mutated metastatic melanoma were retrieved fr...

Full description

Bibliographic Details
Main Authors: Adi Kartolo, Jasna Deluce, Wilma M. Hopman, Linda Liu, Tara Baetz, Scott Ernst, John G. Lenehan
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Current Oncology
Subjects:
BRAF mutant
melanoma
targeted therapy
immunotherapy
therapy sequencing
Online Access:https://www.mdpi.com/1718-7729/29/3/126

Internet

https://www.mdpi.com/1718-7729/29/3/126

Similar Items